Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University Durham, NC, USA.
Children's Hospital of Philadelphia Research Institute, Pennsylvania, PA, USA.
Tumour Biol. 2022;44(1):107-127. doi: 10.3233/TUB-211568.
MicroRNAs (miRNAs) are the small non-coding regulatory RNA molecules involved in gene regulation via base-pairing with complementary sequences in mRNAs. The dysregulation of specific miRNAs, such as miR-99b-5p (miR-99b), is associated with prostate cancer (PCa) progression. However, the mechanistic role of miR-99b in PCa remains to be determined. In this study, we aimed to investigate the functional and clinical significance of miR-99b in PCa.
The expression of miR-99b and its downstream targets mTOR/AR in the PCa samples were analyzed by RT/qPCR. The effects of miR-99b overexpression/inhibition on PCa cell survival/proliferation, spheroid formation, and cell migration were examined by specific assays. Luciferase reporter assays were performed to determine the binding of miR-99b to 3' untranslated region (UTR) of the mTOR gene. The effects of miR-99b on the expression of mTOR, AR, and PSA proteins, as well as on AKT/mTOR signaling, autophagy, and neuroendocrine differentiation markers were analyzed by western blotting. The expression of miR-99b, mTOR, AR, PSA in AR-negative PC3 and AR-positive LNCaP cells was analyzed by RT/qPCR. The effect of miR-99b on global gene expression in PC3 cells was analyzed by RNA-seq.
The expression of miR-99b was downregulated in tumor samples from PCa patients, whereas the expression of mTOR and AR was upregulated. In PCa cell lines, overexpression of miR-99b inhibited cell proliferation and cell colony/spheroid formation; induced apoptosis, and increased sensitivity towards docetaxel (DTX). In contrast, inhibition of miR-99b by miR-99b inhibitor resulted in increased cell growth in PCa cells. Mechanistically, miR-99b inhibited the expression of the mammalian target of the rapamycin (mTOR) gene by binding to its 3' UTR and induced autophagy. Furthermore, miR-99b inhibited androgen receptor (AR) activity in LNCaP cells and induced apoptosis. Activation of AR signaling by dihydrotestosterone (DHT) downregulated miR-99b expression and promoted cell PCa cell growth/survival, whereas inactivation of mTOR by rapamycin or AR by enzalutamide decreased miR-99b mediated PCa cell growth.
Our data suggest that miR-99b functions as a tumor suppressor by targeting the mTOR/AR axis in PCa cells, implicating miR-99b as a novel biomarker and therapeutic target for PCa management.
MicroRNAs(miRNAs)是通过与 mRNA 中的互补序列碱基配对来参与基因调控的小非编码调节 RNA 分子。特定 miRNAs(如 miR-99b-5p(miR-99b))的失调与前列腺癌(PCa)的进展有关。然而,miR-99b 在 PCa 中的作用机制仍有待确定。在这项研究中,我们旨在研究 miR-99b 在 PCa 中的功能和临床意义。
通过 RT/qPCR 分析 PCa 样本中 miR-99b 及其下游靶标 mTOR/AR 的表达。通过特定的测定法检查 miR-99b 过表达/抑制对 PCa 细胞存活/增殖、球体形成和细胞迁移的影响。通过荧光素酶报告基因测定法确定 miR-99b 与 mTOR 基因 3'非翻译区(UTR)的结合。通过 Western blot 分析 miR-99b 对 mTOR、AR 和 PSA 蛋白表达以及 AKT/mTOR 信号转导、自噬和神经内分泌分化标志物的影响。通过 RT/qPCR 分析 AR 阴性 PC3 和 AR 阳性 LNCaP 细胞中 miR-99b、mTOR、AR 和 PSA 的表达。通过 RNA-seq 分析 miR-99b 对 PC3 细胞中全局基因表达的影响。
miR-99b 在来自 PCa 患者的肿瘤样本中表达下调,而 mTOR 和 AR 的表达上调。在 PCa 细胞系中,miR-99b 的过表达抑制了细胞增殖和细胞集落/球体形成;诱导细胞凋亡,并增加了对多西他赛(DTX)的敏感性。相比之下,miR-99b 抑制剂抑制 miR-99b 的表达会导致 PCa 细胞中的细胞生长增加。在机制上,miR-99b 通过结合其 3'UTR 抑制哺乳动物雷帕霉素靶蛋白(mTOR)基因的表达并诱导自噬。此外,miR-99b 在 LNCaP 细胞中抑制雄激素受体(AR)活性并诱导细胞凋亡。二氢睾酮(DHT)激活 AR 信号转导下调 miR-99b 的表达并促进 PCa 细胞生长/存活,而雷帕霉素抑制 mTOR 或恩扎卢胺抑制 AR 可降低 miR-99b 介导的 PCa 细胞生长。
我们的数据表明,miR-99b 通过靶向 PCa 细胞中的 mTOR/AR 轴发挥肿瘤抑制作用,提示 miR-99b 作为一种新的生物标志物和治疗靶点用于 PCa 的管理。